As the director of the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS), I invite you to explore our website, learn as much as you can about multiple myeloma and related diseases, and let us know how we can be of assistance to you.
We are dedicated to providing our patients with the very best care based on their individual needs and supported by our in-depth understanding of myeloma biology. As no two patients are exactly alike, we use advanced genomic diagnostic tools to define the molecular characteristics of each patient’s disease, and then create a customized course of targeted, precision treatment. The goal is to attack the diseased cells while leaving healthy cells unharmed. Additionally, we target the diseased cells at all stages of their development, thereby maximizing remission and cure rates.
Moreover, we utilize a “team approach” for truly comprehensive care. On our team are myeloma physicians and specialists from multiple disciplines, including Radiology, Pathology, Endocrinology, Cardiology, Nephrology and Orthopaedics, as well as advanced practice nurses, pharmacists, social workers and dieticians. We also have access to a complete array of services for our patients at UAMS.
The Myeloma Institute, a global Center of Excellence, has developed innovations that have taken us directly from research to treatment of patients. Our patients represent all age groups, levels of disease and nationalities.
The tremendous strides we have made in changing the outcome for patients stem from novel research and its applications, including:
- Cytogenetic research to identify chromosomal prognostic factors
- Genetic chip analysis to identify high-risk and low-risk disease
- Molecular classification of myeloma subtypes
- Personalized therapy based on each patient’s disease factors
The phenomenal growth of the Myeloma Institute at UAMS is marked by distinct milestones:
- More than 11,750 new patients have chosen to come to the Myeloma Institute for treatment
- More than 50 countries on six continents are represented in our patient population
- More than 9,000 stem cell transplants have been performed
With a solid foundation of excellence, a brilliant and dedicated staff, and global partnerships, we are moving forward with firm resolve to make multiple myeloma a distant memory.